Editas Medicine (EDIT) Other Accumulated Expenses (2015 - 2023)

Editas Medicine (EDIT) has 9 years of Other Accumulated Expenses data on file, last reported at $78000.0 in Q2 2023.

• Other Accumulated Expenses for Q2 2023 came in at $78000.0, down 97.18% year-over-year; the trailing twelve-month figure through Jun 2023 was $78000.0 (down 97.18% YoY), and the FY2022 annual result was $1.6 million, up 16.12% from the prior year.
• Other Accumulated Expenses slipped to $78000.0 in Q2 2023 per EDIT's latest filing, from $109000.0 in the prior quarter.
• Over five years, Other Accumulated Expenses peaked at $2.8 million in Q2 2022 and troughed at $78000.0 in Q2 2023.
• A 5-year average of $991222.2 and a median of $862000.0 in 2021 frame the typical range for Other Accumulated Expenses.
• The sharpest annual moves came in 2019 and 2023: Other Accumulated Expenses surged 364.5% in 2019, then sank 97.18% in 2023.
• A 5-year view of Other Accumulated Expenses shows it stood at $2.7 million in 2019, then sank by 57.87% to $1.1 million in 2020, then grew by 24.6% to $1.4 million in 2021, then gained by 16.12% to $1.6 million in 2022, then tumbled by 95.23% to $78000.0 in 2023.
• Business Quant data shows EDIT's Other Accumulated Expenses at $78000.0 in Q2 2023, $109000.0 in Q1 2023, and $1.6 million in Q4 2022.